None

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 70.4% to close at $18.78 after the company on Friday announced a $6 million private placement priced at $8.68 per share. Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares surged 65% to close at $38.11 on Monday after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. PolyPid Ltd. (NASDAQ: PYPD) gained 58.3% to close at $1.71. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week. Arqit Quantum Inc. (NASDAQ: ARQQ) shares gained 38.1% to close at $7.72. The company will present at the H.C. Wainwright 24th Annual Global Investment Conference later today. PaxMedica, Inc. (NASDAQ: PXMD) rose 36.6% to settle at $4.33 after TardiMed Sciences' Michael Derby on Friday disclosed a 63.4% active stake in the company. Allego N.V. (NYSE: ALLG) jumped 33.5% to close at $5.90. IDEAYA Biosciences, Inc. (NASDAQ: IDYA) jumped 30.7% to close at $12.09. IDEAYA Biosciences disclosed interim Phase 2 clinical results for darovasertib and crizotinib synthetic lethal combination in metastatic uveal melanoma. Clovis Oncology, Inc. (NASDAQ: CLVS) climbed 30.4% to close at $1.50 after the company said Rubraca (Rucaparib) as first-line maintenance treatment improves progression-free survival in women with advanced ovarian cancer across disease risk subgroups. Annovis Bio, Inc. (NYSE: ANVS) gained 29.5% to settle at $19.82 on above-average volume. Kaspien Holdings Inc. (NASDAQ: KSPN) surged 27.7% to close at $2.86. IHS Holding Limited (NYSE: IHS) jumped 24.9% to close at $7.83. IHS Holding, last month, said Q2 EPS results down year-over-year. Gogoro Inc. (NASDAQ: GGR) gained 21.3% to close at $5.25. Gogoro recently launched its battery-swapping system and Smart scooters in the Tel Aviv metropolitan area. ImmunityBio, Inc. (NASDAQ: IBRX) jumped 20.9% to close at $5.61. POINT Biopharma Global Inc. (NASDAQ: PNT) rose 19.8% to close at $10.27 after the company published a poster at ESMO Congress 2022 highlighting updated safety and efficacy data from its Phase 3 SPLASH trial of PNT2002 in metastatic castration-resistant prostate cancer. Rackspace Technology, Inc. (NASDAQ: RXT) gained 18.8% to settle at $6.32. Magic Empire Global Limited (NASDAQ: MEGL) jumped 17.9% to close at $6.00. Regulus Therapeutics Inc. (NASDAQ: RGLS) rose 16.9% to close at $1.94 after the company announced topline safety and PK data from its Phase 1 SAD clinical trial of RGLS8429. The study demonstrated that RGLS8429 has a favorable safety and PK profile. TuanChe Limited (NASDAQ: TC) gained 16.8% to close at $3.20. Asana, Inc. (NYSE: ASAN) climbed 16.4% to close ...

Related tickers: GSHD, FOA, TUEM, NRBO, REBN, HYPR, GGR, IBRX, VTNR, YOSH, MOGU, NTCT, NUWE, RGLS, IDYA, STRC, LCID, W, NIO, UG, CLAQ, RYTM, ANPC, BMY, ARQQ, INM, AYLA, IHS, SGML, AKTX, WETG, IPI, DICE, PNT, INLX, PYPD, TC, VTYX, LPTX, IMTX, GPL, TRDA, CVNA, QH, GNTA, CDRO, RMED, RXT, ASAN, EVEX, PIXY, KSPN, SWTX, ALLG, AREB, PXMD, CLVS, LSAK, RBBN, AUUD, IDAI, MEGL, CDLX, BBIG, ANVS, APGN.

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) gained 69% to $0.4664 after the company announced a 1-for-30 reverse stock split. Arqit Quantum Inc. (NASDAQ: ARQQ) shares climbed 34.7% to $7.53. The company will present at the H.C. Wainwright 24th Annual Global Investment Conference later today. InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 32.5% to $14.60 after the company on Friday announced a $6 million private placement priced at $8.68 per share. Ra Medical Systems, Inc. (NYSE: RMED) surged 28% to $0.1865 after the company announced a merger agreement with Catheter Precision. Catheter Precision will become a wholly owned subsidiary of Ra Medical. Vinco Ventures, Inc. (NASDAQ: BBIG) gained 25% to $1.2500. IHS Holding Limited (NYSE: IHS) jumped 19.2% to $7.47. IHS Holding, last month, said Q2 EPS results down year-over-year. Gogoro Inc. (NASDAQ: GGR) gained 19.1% to $5.16. Gogoro recently launched its battery-swapping system and Smart scooters in the Tel Aviv metropolitan area. Ribbon Communications Inc. (NASDAQ: RBBN) rose 19% to $3.8450. Allego N.V. (NYSE: ALLG) gained 18.3% to $5.23. Regulus Therapeutics Inc. (NASDAQ: RGLS) gained 16.8% to $1.94 after the company announced topline safety and PK data from its Phase 1 SAD clinical trial of RGLS8429. The study demonstrated that RGLS8429 has a favorable safety and PK profile. IDEAYA Biosciences, Inc. (NASDAQ: IDYA) surged 15.6% to $10.70. IDEAYA Biosciences disclosed interim Phase 2 clinical results for darovasertib and crizotinib synthetic lethal combination in metastatic uveal melanoma. Carvana Co. (NYSE: CVNA) rose 13.7% to $41.64. Piper Sandler upgraded Carvana from Neutral to Overweight and lowered the price target from $98 to $73. POINT Biopharma Global Inc. (NASDAQ: PNT) gained 13.4% to $9.72 after the company published a poster at ESMO Congress 2022 highlighting updated safety ...

Related tickers: NUWE, GGR, LPTX, CLAQ, NTCT, CVNA, ARQQ, SPPI, RMED, SGML, BMY, PIXY, DICE, IHS, RBBN, VTYX, GPL, HYPR, TRDA, GNTA, MOGU, CDRO, ASAN, IDYA, EVEX, CLVS, NIO, ALLG, NRBO, AYLA, APGN, RGLS, IMTX, QH, REBN, BNR, DMS, SHPH, INM, AUUD, YOSH, AKTX, BBIG, PNT, TUEM, AZRE.